Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Assets Average: 2024-2025

Historic Assets Average for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to $715.7 million.

  • CG Oncology's Assets Average rose 28.17% to $715.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $715.7 million, marking a year-over-year increase of 28.17%. This contributed to the annual value of $477.0 million for FY2024, which is N/A change from last year.
  • Latest data reveals that CG Oncology reported Assets Average of $715.7 million as of Q3 2025, which was up 0.12% from $714.8 million recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Assets Average registered a high of $741.5 million during Q1 2025, and its lowest value of $389.2 million during Q1 2024.
  • Over the past 2 years, CG Oncology's median Assets Average value was $653.6 million (recorded in 2024), while the average stood at $620.7 million.
  • Data for CG Oncology's Assets Average shows a peak YoY surged of 90.51% (in 2025) over the last 5 years.
  • Quarterly analysis of 2 years shows CG Oncology's Assets Average stood at $653.6 million in 2024, then grew by 28.17% to $715.7 million in 2025.
  • Its Assets Average was $715.7 million in Q3 2025, compared to $714.8 million in Q2 2025 and $741.5 million in Q1 2025.